Oxford University and British pharmaceutical giant AstraZeneca say their vaccine for the novel coronavirus could be around 70% effective under one dosing regimen.
In a tweet, the University of Oxford announced what they said was an important milestone in the fight against #COVID19
It said Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving people one step closer in supplying it at low cost around the world.
It went on to say that the project is the result of global collaboration and support from partners, funders and researchers around the world.
The vaccine developed in the UK by AstraZeneca and Oxford University ‘will save many lives’, says scientist.
AstraZeneca said it is making rapid progress in manufacturing with a capacity of up to 3 billion doses of the vaccine in 2021 on a rolling basis, pending regulatory approval.
The vaccine can be stored, transported and handled at normal refrigerated conditions for at least six months and administered within existing healthcare settings.
However, salient concerns remain which is that conducting science too fast could risk compromising the rigour needed to properly assess vaccines.
Discover more from LN247
Subscribe to get the latest posts sent to your email.
